Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate
Hand-out
Press Releases
Ratio Therapeutics Inc.  
November 18, 2024

Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate

Ratio to receive upfront, and potential milestones and tiered royalty payments

avatar profile Olean Times Herald

Olean Times Herald


Local & Social